Impact of Drosophila Models in the Study and Treatment of Friedreich’s Ataxia

Impact of Drosophila Models in the Study and Treatment of Friedreich’s Ataxia

Drosophila melanogaster has been for over a century the model of choice of several neurobiologists to decipher the formation and development of the nervous system as well as to mirror the pathophysiological conditions of many human neurodegenerative diseases. The rare disease Friedreich’s...

Full description

Bibliographic Details
Main Authors:	Véronique Monnier, Jose Vicente Llorens, Juan Antonio Navarro
Format:	Article
Language:	English
Published:	MDPI AG 2018-07-01
Series:	International Journal of Molecular Sciences
Subjects:	Drosophila melanogaster Friedreich’s ataxia frataxin iron oxidative stress metal homeostasis lipid metabolism endoplasmic reticulum genetic screens drug screens
Online Access:	http://www.mdpi.com/1422-0067/19/7/1989

Similar Items

Friedreichs ataxia in a diabetic patient
by: Inna Igorevna Klefortova, et al.
Published: (2010-06-01)

Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
by: Vijayendran Chandran, et al.
Published: (2017-12-01)

The Role of Iron in Friedreich’s Ataxia: Insights From Studies in Human Tissues and Cellular and Animal Models
by: José Vicente Llorens, et al.
Published: (2019-02-01)

Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?
by: Sylvia Boesch, et al.
Published: (2019-04-01)

Friedreich's Ataxia – A Clinical Diagnosis
by: Md. Fekarul Islam, et al.
Published: (2015-01-01)

Identification of cardioprotective drugs by medium-scale in vivo pharmacological screening on a Drosophila cardiac model of Friedreich's ataxia
by: Amandine Palandri, et al.
Published: (2018-07-01)

Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation
by: Alain eMartelli, et al.
Published: (2014-06-01)

ALTERATIONS OF MITOCHONDRIAL BIOGENESIS AND ALTERATIONS OF MITOCHONDRIAL ANTIOXIDANT DEFENSE IN FRIEDREICH’S ATAXIA
by: Marmolino, Daniele
Published: (2011)

Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell model
by: Tommaso Vannocci, et al.
Published: (2018-06-01)

Mitofusin-Dependent ER Stress Triggers Glial Dysfunction and Nervous System Degeneration in a Drosophila Model of Friedreich’s Ataxia
by: Oliver Edenharter, et al.
Published: (2018-03-01)

Epigenetic-based therapies for Friedreich ataxia
by: Chiranjeevi eSandi, et al.
Published: (2014-06-01)

Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells
by: Alessandra Rufini, et al.
Published: (2015-03-01)

Overcoming frataxin gene silencing in Friedreich’s ataxia with small molecules: studies on cellular and animal models
by: Rai, Myriam
Published: (2010)

HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich’s Ataxia
by: Mursal Sherzai, et al.
Published: (2020-06-01)

Mechanism of action of 2-aminobenzamide HDAC inhibitors in reversing gene silencing in Friedreich’s ataxia
by: Elisabetta eSoragni, et al.
Published: (2015-03-01)

A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins
by: Pierre Chapdelaine, et al.
Published: (2013-01-01)

Time-resolved functional analysis of acute impairment of frataxin expression in an inducible cell model of Friedreich ataxia
by: Dörte Poburski, et al.
Published: (2016-05-01)

Targeting NRF2 for the Treatment of Friedreich’s Ataxia: A Comparison among Drugs
by: Sara Petrillo, et al.
Published: (2019-10-01)

The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich’s Ataxia
by: Piergiorgio La Rosa, et al.
Published: (2020-01-01)

Liver Growth Factor (LGF) Upregulates Frataxin Protein Expression and Reduces Oxidative Stress in Friedreich’s Ataxia Transgenic Mice
by: Lucía Calatrava-Ferreras, et al.
Published: (2016-12-01)

Altered Secretome and ROS Production in Olfactory Mucosa Stem Cells Derived from Friedreich’s Ataxia Patients
by: Sara Pérez-Luz, et al.
Published: (2020-09-01)

Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia
by: Daniel Fil, et al.
Published: (2020-07-01)

Nrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich’s Ataxia Neural Stem Cells
by: Piergiorgio La Rosa, et al.
Published: (2019-07-01)

Molecular Defects in Friedreich’s Ataxia: Convergence of Oxidative Stress and Cytoskeletal Abnormalities
by: Frances M. Smith, et al.
Published: (2020-11-01)

PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia
by: Laura Rodríguez-Pascau, et al.
Published: (2021-01-01)

Friedreich Ataxia: current status and future prospects
by: Katrin Bürk
Published: (2017-04-01)

Friedreich’s Ataxia with Retained Reflexes
by: J Gordon Millichap
Published: (1995-04-01)

Anesthetic Management on a Patient with Friedreichs Ataxia
by: Ulku Ozgul, et al.
Published: (2013-12-01)

Drp1‐dependent peptide reverse mitochondrial fragmentation, a homeostatic response in Friedreich ataxia
by: Joseph Johnson, et al.
Published: (2021-05-01)

Large Interruptions of GAA Repeat Expansion Mutations in Friedreich Ataxia Are Very Rare
by: Sahar Al-Mahdawi, et al.
Published: (2018-11-01)

Cardiomyopathy as the first manifestation of Friedreich’s ataxia
by: Rafael Tuzino Leite Neves Maffei, et al.
Published: (2021-08-01)

Iron in Friedreich Ataxia: A Central Role in the Pathophysiology or an Epiphenomenon?
by: David Alsina, et al.
Published: (2018-09-01)

The mismatch repair system protects against intergenerational GAA repeat instability in a Friedreich ataxia mouse model
by: Vahid Ezzatizadeh, et al.
Published: (2012-04-01)

Ferroptosis in Friedreich’s Ataxia: A Metal-Induced Neurodegenerative Disease
by: Piergiorgio La Rosa, et al.
Published: (2020-11-01)

Genetics of Friedreich Ataxia
by: J Gordon Millichap
Published: (1997-06-01)

Frataxin (FXN) Based Regulation of the Iron-Sulfur Cluster Assembly Complex
by: Rabb, Jennifer
Published: (2012)

E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia
by: Monica Benini, et al.
Published: (2017-02-01)

Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals
by: Kuchuan Chen, et al.
Published: (2016-11-01)

Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration
by: Kuchuan Chen, et al.
Published: (2016-06-01)

Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
by: Chiranjeevi Sandi, et al.
Published: (2011-06-01)